Shelter Ins Retirement Plan Gilead Sciences, Inc. Transaction History

Shelter Ins Retirement Plan

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 25, 2024	BUY	$63.15 - $72.88 $2.03 Million - $2.34 Million	32,110 New	32,110 $2.2 Million
Q3 2019 Nov 21, 2019	SELL	$62.51 - $69.0 $2.21 Million - $2.44 Million	-35,400 Closed	0 $0
Q4 2018 Feb 13, 2019	SELL	$60.54 - $79.0 $163,458 - $213,300	-2,700 Reduced 7.09%	35,400 $2.21 Million
Q2 2018 Jul 23, 2018	SELL	$64.88 - $75.68 $304,936 - $355,696	-4,700 Reduced 10.98%	38,100 $2.7 Million
Q3 2017 Nov 03, 2017	SELL	$72.11 - $85.47 $165,853 - $196,581	-2,300 Reduced 5.1%	42,800 $3.47 Million
Q2 2017 Aug 08, 2017	BUY	N/A	45,100	45,100 $3.19 Million

1,893

1.02B

12M

9.04M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Shelter Ins Retirement Plan, based on Form 13F filings with the SEC.

Stay updated on Shelter Ins Retirement Plan with notifications on news.